Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis

Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis

Evidence regarding the association between body mass index (BMI) and immune-related adverse events (irAEs) among cancer patients receiving immune checkpoint inhibitors (ICIs) is limited. Here, we use cross-sectional hospital-based data to explore their relationship. Pre-treatment BMI was treated as...

Full description

Bibliographic Details
Main Authors: Dongyu Zhang, Neil J. Shah, Michael Cook, Matthew Blackburn, Michael T. Serzan, Shailesh Advani, Arnold L. Potosky, Subha Madhavan, Anas Belouali, Michael B. Atkins, Dejana Braithwaite
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
immune checkpoint inhibitor
body mass index
immune-related adverse events
epidemiology
Online Access:https://www.mdpi.com/2072-6694/13/23/6109

Internet

https://www.mdpi.com/2072-6694/13/23/6109

Similar Items